Palisade Bio (PALI) FCF Margin (2011 - 2023)
Palisade Bio (PALI) reported FCF Margin of 1410.4% for Q1 2023, up 97.72% on a QoQ basis from 61960.0% in Q4 2020.
Palisade Bio (PALI) has 11 years of FCF Margin data on file, last reported at 1410.4% in Q1 2023.
- Quarterly FCF Margin changed N/A year-over-year to 1410.4% in Q1 2023, while the trailing twelve-month figure through Dec 2023 was 4453.2% (changed N/A YoY) and the FY2023 annual result came in at 4454.8%, changed N/A from the prior year.
- FCF Margin grew to 1410.4% in Q1 2023 per PALI's latest filing, from 61960.0% in the prior quarter.
- Across five years, FCF Margin topped out at 1410.4% in Q1 2023 and bottomed at 81957.28% in Q4 2019.
- The 3-year median for FCF Margin is 34720.0% (2020), against an average of 44244.09%.
- The widest annual swing landed in 2019, when FCF Margin plunged 1982152 bps; it then soared 4116960 bps in 2020.
- Tracing PALI's FCF Margin over 3 years: stood at 81957.28% in 2019, then climbed by 24 bps to 61960.0% in 2020, then surged by 98 bps to 1410.4% in 2023.
- Per Business Quant, the three latest PALI FCF Margin figures stand at 1410.4% (Q1 2023), 61960.0% (Q4 2020), and 34720.0% (Q3 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.17% |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -1,410.40% |
| Dec 31, 2020 | -61,960.00% |
| Sep 30, 2020 | -34,720.00% |
| Jun 30, 2020 | -26,934.84% |
| Mar 31, 2020 | -27,867.59% |
| Dec 31, 2019 | -81,957.28% |
| Sep 30, 2019 | -75,889.60% |
| Jun 30, 2019 | -20,820.91% |
| Mar 31, 2019 | -66,636.20% |
| Dec 31, 2018 | -66,321.20% |
| Sep 30, 2018 | -66,558.32% |
| Jun 30, 2018 | -999.40% |
| Mar 31, 2018 | -73,877.96% |
| Dec 31, 2017 | -905.54% |
| Sep 30, 2017 | -132,966.84% |
| Jun 30, 2017 | -134,851.12% |
| Mar 31, 2017 | -177,438.48% |
| Dec 31, 2016 | -46,653.99% |
| Sep 30, 2016 | -179,033.04% |
| Jun 30, 2016 | -146,207.72% |
| Mar 31, 2016 | -140,112.76% |
| Dec 31, 2015 | -157,892.84% |
| Sep 30, 2015 | -221,615.56% |
| Jun 30, 2015 | -195,374.20% |
| Mar 31, 2015 | -162,354.23% |
| Dec 31, 2014 | -75,355.21% |
| Sep 30, 2014 | -62,570.88% |
| Jun 30, 2014 | -48,921.04% |
| Mar 31, 2014 | -67,768.44% |
| Dec 31, 2013 | -99,294.48% |
| Sep 30, 2013 | -94,277.12% |
| Jun 30, 2013 | -134,532.20% |
| Mar 31, 2013 | -2,453.06% |
| Dec 31, 2012 | -101,091.24% |
| Sep 30, 2012 | -831.65% |
| Jun 30, 2012 | -3,159.41% |
| Mar 31, 2012 | -1,344.39% |
| Dec 31, 2011 | -623.93% |
| Sep 30, 2011 | -1,758.96% |